Potential of sanguiin H-6, a component of Sanguisorbae Radix, to protect against oxidative damage in renal mitochondria and apoptosis mediated by peroxynitrite (ONOO) was examined using a model in which rats were injected with lipopolysaccharide (LPS) and then subjected to renal ischemia followed reperfusion (LPS plus ischemia-reperfusion). Ischemia-reperfusion was achieved by occluding bilateral renal artery for 60 min and then releasing for 350 min. At 50 min after ischemia started, LPS was injected intravenously. LPS plus ischemia-reperfusion induced a large amount of 3-nitrotyrosine, an oxidative product of protein that is produced via ONOO nitration, which was not detectable in normal group. Oxidative damage of mitochondria was indicated by an accumulated thiobarbituric acid (TBA)-reactive substance, glutathione (GSH) depletion and glutathione peroxidase (GSH-Px) inactivation in the mitochondria. Treatment of rats with sanguiin H-6 (10 mg/kg body weight/day) for 30 days prior to LPS plus ischemia-reperfusion attenuated the oxidative damage in the mitochondria. The amount of TBA-reactive substance was decreased and the GSH levels significantly increased as compared with that in control group. However, its effect on GSH-Px activity was much weaker. Apoptosis induced by LPS plus ischemia-reperfusion was detected by fluorescence staining, TdT-mediated dUTP-biotin nick end labeling and electrophoretic analysis. Sanguiin H-6 appeared to inhibit apoptosis, and this was associated with the suppression of caspase-3 activity. These beneficial effects of sanguiin H-6 against oxidative damage in mitochondria and apoptosis contributed to the improvement in renal function by reversing the elevated levels of blood urea nitrogen and creatinine caused by ONOO.

1.
Fehsel K, Kroncke KD, Kolb-Bachofen V: The action of NO and its role in autoimmune diabetes mellitus. Res Immunol 1995;146:711–715.
2.
Galle J, Wanner C: Impact of nitric oxide on renal hemodynamics and glomerular function: Modulation by atherogenic lipoproteins? Kidney Blood Pressure Res 1996;19:2–15.
3.
Kone BC: Nitric oxide in renal health and disease. Am J Kid Dis 1997;30:311–333.
4.
Craven PA, DeRubertis FR, Melhem M: Nitric oxide in diabetic nephropathy. Kidney Int 1997;60:S46–S53.
5.
Goligorsky MS, Noiri E: Duality of nitric oxide in acute renal injury. Semin Nephrol 1999;19:263–271.
6.
Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with pligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:2377–2383.
7.
Ketteler M, Abou-Rebyeh F, Frey A, Gawlik A, Peters H, Westenfeld R, Distler A: Nitric oxide, L-arginine and the kidney. Experimental studies of new therapy approaches. Medizinische Klinik 1998;93:15–21.
8.
Heeringa P, van Goor H, Moshage H, Klok PA, Huitema MG, de Jager A, Schep AJ, Kallenberg CG: Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int 1998;53:382–393.
9.
Althaus JS, Oien TT, Fici GJ, Scherch HM, Sethy VH, VonVoigtlander PF: Structure activity relationships of peroxynitrite scavengers and approach to nitric oxide neurotoxicity. Res Commun Chem Pathol Pharmacol 1994;83:243–254.
10.
Southan GJ, Szabo C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996;51:383–394.
11.
Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R: Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997;272:9030–9036.
12.
Kim OK, Murakami A, Nakamura Y, Ohigashi H: Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Cancer Lett 1998;125:199–207.
13.
Haenen GR, Paquay JB, Korthouwer RE, Bast A: Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 1997;236:591–593.
14.
Yokozawa T, Chen CP, Tanaka T: Direct scavening of nitric oxide by traditional crude drugs. Phytomed 1999;6:453–463.
15.
Chen CP, Yokozawa T, Kitani K: Beneficial effects of Sanguisorbae Radix in renal dysfunction caused by endotoxin in vivo. Biol Pharm Bull 1999;22:1327–1330.
16.
Chen CP, Yokozawa T, Sekiya M, Hattori M, Tanaka T: Protective effect of Sanguisorbae Radix against peroxynitrite-mediated renal injury. J Trad Med 2001;18:1–7.
17.
Yokozawa T, Chen CP: Evidence suggesting a nitric oxide scavenging activity for traditional crude drugs and action mechanisms of Sanguisorbae Radix against oxidative stress and aging. J Am Aging Assoc 2001;24:19–30.
18.
Yokozawa T, Chen CP, Tanaka T, Kitani K: A study on the nitric oxide production-suppressing activity of Sanguisorbae Radix components. Biol Pharm Bull 2000;23:717–722.
19.
Zoratti M, Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139–176.
20.
Cassina A, Radi R: Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996;328:309–316.
21.
Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996;271:C1424–C1437.
22.
Brown GC: Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999;1411:351–369.
23.
Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet A: Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. J Biol Chem 1996;271:19199–19208.
24.
Skinner KA, Crow JP, Skinner HB, Chandler RT, Thompson JA, Parks DA: Free and protein-associated nitrotyrosine formation following rat liver preservation and transplantation. Arch Biochem Biophys 1997;342:282–288.
25.
Jung K, Pergande M: Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 1985;183:167–169.
26.
Uchiyama M, Mihara M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271–278.
27.
Hissin PJ, Hilf R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214–226.
28.
Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–77.
29.
Itzhaki RF, Gill DM: A micro-biuret method for estimating proteins. Anal Biochem 1964;9:401–410.
30.
Katoh K, Ikata T, Katoh S, Hamada Y, Nakauchi K, Sano T, Niwa M: Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci Lett 1996;216:9–12.
31.
Hayami S, Ikeda K, Sun F, Tanaka K, Kojo S: Increase of caspase-3 activity in rat liver and plasma by thioacetamide. Biochem Pharmacol 1999;58:1941–1943.
32.
Chakraborti T, Das S, Mondal M, Roychoudhury S, Chakraborti S: Oxidant, mitochondria and calcium: An overview. Cell Signal 1999;11:77–85.
33.
Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS: Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000;86:960–966.
34.
Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R: Cytochrome c nitration by peroxynitrite. J Biol Chem 2000;275:21409–21415.
35.
Keller JN, Mattson MP: Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998;9:105–116.
36.
Gadelha FR, Thomson L, Fagian MM, Costa AD, Radi R, Vercesi AE: Ca2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch Biochem Biophys 1997;345:243–250.
37.
Hall AG: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999;29:238–245.
38.
Virag L, Scott GS, Antal-Szalmas P, O’Connor M, Ohshima H, Szabo C: Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharm 1999;56:824–833.
39.
Santos AC, Uyemura SA, Lopes JL, Bazon JN, Mingatto FE, Curti C: Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria. Free Rad Biol Med 1998;24:1455–1461.
40.
Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Ann Rev Physiol 1998;60:619–642.
41.
Lin KT, Xue JY, Wong PY: Mechanisms of peroxynitrite-induced apoptosis in HL-60 cells. Adv Exp Med Biol 1999;469:569–575.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.